CIK 1131399
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 94.82% | 11 |
| Unclassified | 3.59% | 1 |
| Health Care Equipment & Supplies | 1.59% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | Health Care | 25.57% |
| 2 | WVE | Wave Life Sciences Ltd. | Health Care | 22.08% |
| 3 | BNTX | BioNTech SE | Health Care | 13.20% |
| 4 | VIR | Vir Biotechnology, Inc. | Health Care | 12.79% |
| 5 | IDYA | IDEAYA Biosciences, Inc. | Health Care | 7.41% |
| 6 | LYEL | Lyell Immunopharma, Inc. | Health Care | 5.06% |
| 7 | CYTK | CYTOKINETICS INC | Health Care | 3.74% |
| 8 | SPRO | SPERO THERAPEUTICS INC | Unclassified | 3.59% |
| 9 | FULC | Fulcrum Therapeutics, Inc. | Health Care | 2.29% |
| 10 | CVRX | CVRx, Inc. | Health Care | 1.59% |
12/13 names classified · sector 96.4% of weight · industry 96.4% · mkt cap 83.2%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 96.4% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/13 names) · unclassified 100.0%: CRSP, WVE, BNTX, VIR, IDYA, LYEL, CYTK, SPRO, FULC, CVRX +3 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | CRSPCRISPR THERAPEUTICS AG | 3,220,627 | $153M | 25.6% | HOLD |
| 2 | WVEWAVE LIFE SCIENCES LTD | 18,245,691 | $132M | 22.1% | HOLD |
| 3 | BNTXBIONTECH SE | 889,824 | $79M | 13.2% | HOLD |
| 4 | VIRVIR BIOTECHNOLOGY INC | 8,550,954 | $77M | 12.8% | HOLD |
| 5 | IDYAIDEAYA BIOSCIENCES INC | 1,333,333 | $44M | 7.4% | HOLD |
| 6 | LYELLYELL IMMUNOPHARMA INC | 1,512,659 | $30M | 5.1% | HOLD |
| 7 | CYTKCYTOKINETICS INC | 340,434 | $22M | 3.7% | HOLD |
| 8 | SPROSPERO THERAPEUTICS INC | 9,190,606 | $22M | 3.6% | HOLD |
| 9 | FULCFULCRUM THERAPEUTICS INC | 1,785,714 | $14M | 2.3% | HOLD |
| 10 | CVRXCVRX INC | 1,007,583 | $10M | 1.6% | HOLD |
| 11 | BCYCBICYCLE THERAPEUTICS PLC | 1,529,561 | $7M | 1.2% | HOLD |
| 12 | NKTXNKARTA INC | 3,150,732 | $7M | 1.1% | HOLD |
| 13 | RGNXREGENXBIO INC | 271,456 | $2M | 0.4% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| CRSPCRISPR THERAPEUTICS AG | — | — | — | — | 3.2M | 3.2M | $153M |
| WVEWAVE LIFE SCIENCES LTD | — | — | — | — | 18.2M | 18.2M | $132M |
| BNTXBIONTECH SE | — | — | — | — | 890K | 890K | $79M |
| VIRVIR BIOTECHNOLOGY INC | — | — | — | — | 8.6M | 8.6M | $77M |
| IDYAIDEAYA BIOSCIENCES INC | — | — | — | — | 1.3M | 1.3M | $44M |
| LYELLYELL IMMUNOPHARMA INC | — | — | — | — | 1.5M | 1.5M | $30M |
| CYTKCYTOKINETICS INC | — | — | — | — | 340K | 340K | $22M |
| SPROSPERO THERAPEUTICS INC | — | — | — | — | 9.2M | 9.2M | $22M |
| FULCFULCRUM THERAPEUTICS INC | — | — | — | — | 1.8M | 1.8M | $14M |
| CVRXCVRX INC | — | — | — | — | 1.0M | 1.0M | $10M |
| BCYCBICYCLE THERAPEUTICS PLC | — | — | — | — | 1.5M | 1.5M | $7M |
| NKTXNKARTA INC | — | — | — | — | 3.2M | 3.2M | $7M |
| RGNXREGENXBIO INC | — | — | — | — | 271K | 271K | $2M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
